Carthagenetics

Carthagenetics

Teilen

CarthaGeneticsยฎ: Your Orphan Drug Companion! ๐˜พ๐™–๐™ง๐™ฉ๐™๐™–๐™‚๐™š๐™ฃ๐™š๐™ฉ๐™ž๐™˜๐™จยฎ: ๐™”๐™ค๐™ช๐™ง ๐™Š๐™ง๐™ฅ๐™๐™–๐™ฃ ๐˜ฟ๐™ง๐™ช๐™œ ๐˜พ๐™ค๐™ข๐™ฅ๐™–๐™ฃ๐™ž๐™ค๐™ฃ ! Connect with CarthaGeneticsยฎ today.

Experience the thrill of venturing into uncharted territories with CarthaGeneticsยฎ, a trailblazing consulting firm dedicated to transforming the landscape of rare diseases, advanced therapies, and orphan drugs. Founded in 2004 by the visionary Philippe Carteron, CarthaGeneticsยฎ is on a mission to revolutionize healthcare across Western Europe, Turkey, and North Africa. CarthaGeneticsยฎ has earned its reputation as the go-to partner for the most prestigious biotech and pharma companies, including Cas Alexion, Alnylam, Amicus, Biogen, BioMarin, FoldRX/Pfizer, Genzyme, Horizon, Insmed, Orchard, PTC, RegenXbio, Shire, Ultragenyx, as well as for the Turkish Ministry of Health and Turkish Pharmacist Association (TEB). With an unwavering focus on innovative medicines, particularly in the realm of cell and gene therapies, CarthaGeneticsยฎ brings a wealth of expertise to the table.


๐˜ผ๐™˜๐™˜๐™š๐™ก๐™š๐™ง๐™–๐™ฉ๐™ž๐™ฃ๐™œ ๐™ฎ๐™ค๐™ช๐™ง ๐™˜๐™ก๐™ž๐™ฃ๐™ž๐™˜๐™–๐™ก ๐™ฉ๐™ง๐™ž๐™–๐™ก ๐™š๐™ฃ๐™ง๐™ค๐™ก๐™ก๐™ข๐™š๐™ฃ๐™ฉ
Imagine the exhilaration of accelerating the pace of clinical trials. CarthaGeneticsยฎ excels in patient identification and collaboration with your Contract Research Organizations (CROs), significantly speeding up enrollment. With a strong network in various countries, encompassing renowned medical professionals specializing in various fields, from pediatricians to geneticists, CarthaGeneticsยฎ is poised to revolutionize the research landscape.


๐™‹๐™ž๐™ค๐™ฃ๐™š๐™š๐™ง๐™ž๐™ฃ๐™œ ๐™€๐™–๐™ง๐™ก๐™ฎ ๐˜ผ๐™˜๐™˜๐™š๐™จ๐™จ ๐™‹๐™ง๐™ค๐™œ๐™ง๐™–๐™ข๐™จ
Embark on an extraordinary journey of compassion and hope with CarthaGeneticsยฎ's Early Access Programs. In countries where such programs are permitted, CarthaGeneticsยฎ facilitates compassionate use and named patient sales, providing a lifeline to those in need. From France's Accรจs Prรฉcoce to Italy's Law 648/Law 326 and Turkey's Endikasyon DฤฑลŸฤฑ Kullanฤฑm Kฤฑlavuzu, CarthaGeneticsยฎ empowers patients and healthcare providers alike.


๐™€๐™ญ๐™ฅ๐™–๐™ฃ๐™™๐™ž๐™ฃ๐™œ ๐™ƒ๐™ค๐™ง๐™ž๐™ฏ๐™ค๐™ฃ๐™จ ๐™ฌ๐™ž๐™ฉ๐™ ๐˜ฝ๐™ž๐™ค๐™จ๐™ž๐™ข๐™ž๐™ก๐™–๐™ง๐™จ
Venture into new frontiers of healthcare with CarthaGeneticsยฎ's biosimilars of orphan drugs. In North Africa, where Orphan Drug exclusivity is absent, CarthaGeneticsยฎ is spearheading the development of affordable and accessible treatments. With a population of approximately 100 million, this represents a tremendous opportunity to make a lasting impact.


๐™…๐™ค๐™ž๐™ฃ ๐™ฉ๐™๐™š ๐™…๐™ค๐™ช๐™ง๐™ฃ๐™š๐™ฎ
Ready to embark on an exhilarating adventure in healthcare? Whether you have questions, want to explore collaboration possibilities, or simply seek more information, reach out to us at [email protected] or call our Swiss headquarter at +41 22 575 31 31. Discover more about our groundbreaking work at www.carthagenetics.com. Together, we can redefine the future of rare disease treatment.

18/09/2026

Happy National Day to Chile.
18 September โ€” Fiestas Patrias.
A thought for my friends there, and for the physicians I had the privilege to meet, including colleagues at the Universidad de los Andes.
Chile is a beautiful country. I miss it.
Warm wishes to all who are celebrating.

17/09/2026

World Patient Safety Day โ€” 17 September.
This yearโ€™s focus: safe care for noncommunicable diseases. Safe care for life.
Long-term treatment only works if the system around the patient is careful โ€” diagnosis, medicines, follow-up, and the people who deliver them.
Respect to healthcare professionals, and to patients who place their trust in them.
โ€“ The Carthagenetics Team

15/09/2026

Today is World Lymphoma Awareness Day.

Lymphoma is not one disease. Behind the word are many subtypes โ€” some frequent, others rare, and too often diagnosed late.
At Carthagenetics, we are working on a rare lymphoma. That work reminds us of a simple fact: patients with uncommon forms need the same urgency as everyone else, and often get less of it.
A thought for the patients, the families, and the physicians who navigate this path every day.

13/09/2026

International Chocolate Day.
A short pause. A good square. Switzerland oblige.
โ€“ The Carthagenetics Team

11/09/2026

Our CEO, Philippe Carteron de Balmont, is attending todayโ€™s summer meeting of ATNEA, the Tunisian Association of Child and Adolescent Neurology.
The focus: dysexecutive disorders in neurological diseases.
โ€“ The Carthagenetics Team

11/09/2026

Patriot Day.
September 11th โ€” honoring and remembering.
โ€“ The Carthagenetics Team

10/09/2026

Today Geneva observes the Jeรปne genevois.
The Thursday after the first Sunday of September. The first recorded fast in the city dates back to 1567: a day of humility and solidarity. What remains is simpler โ€” the tarte aux pruneaux, the plum tart once prepared the day before as the only meal allowed.
Geneva has long been part of our company life. A quiet day there still feels like a good reminder to pause.
Warm wishes to friends and colleagues in Geneva.

08/09/2026

Happy National Day to Andorra.
8 September marks the Diada de Meritxell, honouring the patron of the Principality and recalling the historic Pareatge of 1278 that helped define this small but enduring European state.
Even micro-states have patients living with rare diseases. Access and care matter everywhere.
Carthagenetics is dedicated to rare disease patients โ€” from large countries to the smallest ones.
Warm wishes to Andorra.

08/09/2026

Today I am joining a WHO/Europe side event at RC76:
๐—™๐—ฟ๐—ผ๐—บ ๐—–๐—ผ๐—บ๐—บ๐—ถ๐˜๐—บ๐—ฒ๐—ป๐˜๐˜€ ๐˜๐—ผ ๐—–๐—ต๐—ฎ๐—ป๐—ด๐—ฒ โ€” ๐—”๐—ฑ๐˜ƒ๐—ฎ๐—ป๐—ฐ๐—ถ๐—ป๐—ด ๐——๐—ถ๐˜€๐—ฎ๐—ฏ๐—ถ๐—น๐—ถ๐˜๐˜† ๐—ฎ๐—ป๐—ฑ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—˜๐—พ๐˜‚๐—ถ๐˜๐˜† ๐—ผ๐—ป ๐˜๐—ต๐—ฒ ๐—ฅ๐—ผ๐—ฎ๐—ฑ ๐˜๐—ผ ๐—ฎ๐—ป ๐—œ๐—ป๐—ฐ๐—น๐˜‚๐˜€๐—ถ๐˜ƒ๐—ฒ ๐Ÿฎ๐Ÿฌ๐Ÿฏ๐Ÿฌ

2026 marks the midpoint of the WHO European Framework on disability-inclusive health (2022โ€“2030). A useful moment to look at what has moved, what has not, and what still needs to be done by 2030.
Many rare diseases lead to lasting disability. Progress on inclusion and health equity therefore matters directly for these patients and their families.
Listening today to WHO/Europe, Member States and people with lived experience.

07/09/2026

Our CEO Philippe Carteron de Balmont, alumnus of the Graduate Institute Geneva, will attend today's session on ethical leadership in a complex world.
12:30โ€“13:30 CEST

https://executive.graduateinstitute.ch/events/ethical-leadership-complex-world

Wollen Sie Ihr Service zum Top-Technisches Unternehmen in Pully machen?
Klicken Sie hier, um Ihren Gesponserten Eintrag zu erhalten.

Telefon

Adresse


Le Millรฉis, Chemin De Rennier, 6
Pully
1009

ร–ffnungszeiten

Montag 09:00 - 18:30
Dienstag 09:00 - 18:30
Mittwoch 09:00 - 18:30
Donnerstag 09:00 - 18:30
Freitag 09:00 - 18:30